Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2014-10-20 Interim / Quarterly Rep…
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the six-month period ending June 30, 2014. It includes detailed balance sheets, income statements, and management commentary on financial performance, business trends, and operational highlights. Since it contains actual financial statements for an interim period (half-year) and is not merely an announcement or a certification, it is classified as an Interim/Quarterly Report. H2 2014
2014-10-20 French
GLOBAL BIOENERGIES results for the six months ended June 30th, 2014
Interim / Quarterly Report Classification · 100% confidence The document provides the financial results for the six months ended June 30, 2014, for Global Bioenergies. It includes detailed aggregated balance sheets and income statements, as well as management commentary on the financial performance and recent business highlights. Since it contains substantive financial data for an interim period (six months) and is not merely an announcement of a report, it is classified as an Interim/Quarterly Report. H1 2014
2014-10-20 English
Communicated under the obligation to provide permanent information / Other communications
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces that GLOBAL BIOENERGIES is proceeding with a 'draw down on its Standby Equity Distribution Agreement' with Yorkville Advisors. It details the issuance of 2,700 new shares and the associated pricing mechanism (5% discount). This action directly relates to fundraising, financing activities, and changes in the capital structure (issuance of new shares). This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as the subject matter is highly specific to a financing agreement execution.
2014-10-13 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated October 13, 2014, announcing that Global Bioenergies has executed a new drawdown of 100,000 euros under its existing optional equity financing line with Yorkville Advisors. It explicitly states the issuance of 2,700 new shares and the funds raised, which relates directly to capital structure changes and fundraising activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA).
2014-10-13 French
Global Bioenergies nimmt im Rahmen ihrer SEDA-Vereinbarung (Standby Equity Distribution Agreement) einen weiteren Betrag von 100.000 Euro in Anspruch
Share Issue/Capital Change Classification · 99% confidence The document is a corporate news release dated October 13, 2014, announcing that Global Bioenergies is utilizing a portion of its Standby Equity Distribution Agreement (SEDA) by issuing 2,700 new shares for 100,000 Euros. The key subject is the issuance of new shares and the utilization of a financing agreement, which directly relates to capital structure changes and fundraising activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it involves shares, it is not a general share issue announcement (SHA) but a specific financing mechanism draw-down.
2014-10-13 German
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated October 6, 2014, announcing that Global Bioenergies has executed a drawdown of 100,000 euros under an existing equity financing line with Yorkville Advisors. It details the issuance of 2,600 new shares at a specific price, which is a direct action related to fundraising and capital structure management. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP), which covers company fundraising and capital structure changes. It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA).
2014-10-06 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.